Recital 5, Regulation (EU) 2026/2042

In forcesince 11 Sep 2026

The Commission concurs with the opinion of the Agency and considers it therefore appropriate to grant a Union authorisation for the biocidal product ‘OXTERIL® 350 VHP’.